Cooper I - Search Results

1

Selection of patients for randomised trials: a study based on the MACOP-B vs CHOP in NHL study.

Stone JM, Page FJ, Laidlaw CR, Cooper I. Stone JM, et al. Among authors: cooper i. Aust N Z J Med. 1994 Oct;24(5):536-40. doi: 10.1111/j.1445-5994.1994.tb01754.x. Aust N Z J Med. 1994. PMID: 7531432 Clinical Trial.

2

Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.

Cooper IA, Wolf MM, Robertson TI, Fox RM, Matthews JP, Stone JM, Ding JC, Dart G, Matthews J, Firkin FC, et al. Cooper IA, et al. J Clin Oncol. 1994 Apr;12(4):769-78. doi: 10.1200/JCO.1994.12.4.769. J Clin Oncol. 1994. PMID: 7512131 Clinical Trial.

3

Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.

Wolf M, Matthews JP, Stone J, Cooper IA, Robertson TI, Fox RM. Wolf M, et al. Among authors: cooper ia. Ann Oncol. 1997;8 Suppl 1:71-5. Ann Oncol. 1997. PMID: 9187435 Clinical Trial.

4

Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma.

Juneja S, Matthews J, Lukeis R, Laidlaw C, Cooper I, Wolf M, Ironside P, Garson OM. Juneja S, et al. Among authors: cooper i. Leuk Lymphoma. 1997 May;25(5-6):493-501. doi: 10.3109/10428199709039037. Leuk Lymphoma. 1997. PMID: 9250820

5

Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.

Crennan E, D'Costa I, Liew KH, Thompson J, Laidlaw C, Cooper I, Quong G. Crennan E, et al. Among authors: cooper i. Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):333-7. doi: 10.1016/0360-3016(94)E0136-8. Int J Radiat Oncol Biol Phys. 1995. PMID: 7530700

6

Infradiaphragmatic Hodgkin's disease, long term follow-up of a rare presentation.

Liew KH, Ding JC, Cruickshank D, Quong GG, Wolf MM, Cooper IA. Liew KH, et al. Among authors: cooper ia. Aust N Z J Med. 1991 Feb;21(1):16-21. doi: 10.1111/j.1445-5994.1991.tb02995.x. Aust N Z J Med. 1991. PMID: 2036071

7

A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.

Olver IN, Wolf M, Laidlaw C, Bishop JF, Cooper IA, Matthews J, Smith R, Buchanan L. Olver IN, et al. Among authors: cooper ia. Eur J Cancer. 1992;28A(11):1798-802. doi: 10.1016/0959-8049(92)90006-n. Eur J Cancer. 1992. PMID: 1389512 Clinical Trial.

8

Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.

Matthews JR, Cooper IA, Matthews JP, Ding JC. Matthews JR, et al. Among authors: cooper ia. Aust N Z J Med. 1992 Apr;22(2):123-8. doi: 10.1111/j.1445-5994.1992.tb02790.x. Aust N Z J Med. 1992. PMID: 1530533 Clinical Trial.

9

Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.

Chan T, Juneja S, Wolf M, Januszewicz E, Cooper I. Chan T, et al. Among authors: cooper i. Bone Marrow Transplant. 1994 Feb;13(2):145-8. Bone Marrow Transplant. 1994. PMID: 7515740

10

Association of abnormalities of chromosome 11 with t(14;18) in diffuse non-Hodgkin's lymphoma.

Lukeis R, Juneja S, Tan L, Matthews J, Cooper I, Ironside P, Garson OM. Lukeis R, et al. Among authors: cooper i. Cancer Genet Cytogenet. 1994 Nov;78(1):36-9. doi: 10.1016/0165-4608(94)90043-4. Cancer Genet Cytogenet. 1994. PMID: 7987803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

580 results

Search Page

Filters